文献速递糖尿病肥胖与代谢综合征

糖尿病患者蔬果处方项目的评估:血糖控制的纵向分析

Evaluation of a Produce Prescription Program for Patients With Diabetes: A Longitudinal Analysis of Glycemic Control.
PubMed 文献 · Diabetes Care · 2023-01-01

研究纳入252例接受蔬果处方(每月60美元代金券,共6个月)的糖尿病患者和534例来自康涅狄格州哈特福德两家诊所的相似对照,评估6个月时糖化血红蛋白变化。结果显示干预组与对照组糖化血红蛋白变化无显著差异,差值为0.13个百分点(95%CI -0.05, 0.32)。

要点

  • 6个月蔬果处方项目未显著改善糖尿病患者的血糖控制。
  • 糖化血红蛋白变化组间差值为0.13个百分点(95%CI -0.05, 0.32)。
  • 收缩压、舒张压、BMI及住院和急诊就诊率均无显著差异。

核心结论

  • 在COVID-19大流行初期实施的为期6个月的蔬果处方项目与糖尿病患者血糖控制改善无关。

研究设计与样本

  • 非随机入组252例接受蔬果处方的糖尿病患者和来自康涅狄格州哈特福德两家诊所的534例相似对照。
  • 蔬果处方入组者接受每月60美元代金券,为期6个月,用于在杂货零售店购买蔬果;对照接受常规照护。
  • 主要结局为6个月时治疗组与对照组之间糖化血红蛋白的变化;采用纵向广义估计方程模型,以倾向评分重叠权重加权。

主要发现

  • 6个月时,治疗组与对照组糖化血红蛋白变化无显著差异,差值为0.13个百分点(95%CI -0.05, 0.32)。
  • 收缩压变化无显著差异(3.85 mmHg;95%CI -0.12, 7.82)。
  • 舒张压变化无显著差异(-0.82 mmHg;95%CI -2.42, 0.79)。
  • BMI变化无显著差异(-0.22 kg/m2;95%CI -1.83, 1.38)。
  • 住院和急诊就诊的发病率比分别为0.54(95%CI 0.14, 1.95)和0.53(95%CI 0.06, 4.72)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Produce prescriptions have shown promise in improving diabetes care, although most studies have used small samples or lacked controls. Our objective was to evaluate the impacts of a produce prescription program on glycemic control for patients with diabetes. RESEARCH DESIGN AND METHODS: Participants included a nonrandom enrollment of 252 patients with diabetes who received a produce prescription and 534 similar control participants from two clinics in Hartford, Connecticut. The start of the COVID-19 pandemic in March 2020 coincided with program implementation. Produce prescription enrollees received vouchers ($60 per month) for 6 months to purchase produce at grocery retail. Controls received usual care. The primary outcome was change in glycated hemoglobin (HbA1c) between treatment and control at 6 months. Secondary outcomes included 6-month changes in systolic (SBP) and diastolic blood pressure (DBP), BMI, hospitalizations, and emergency department admissions. Longitudinal generalized estimating equation models, weighted with propensity score overlap weights, assessed changes in outcomes over time. RESULTS: At 6 months, there was no significant difference in change in HbA1c between treatment and control groups, with a difference of 0.13 percentage points (95% CI -0.05, 0.32). No significant difference was observed for change in SBP (3.85 mmHg; -0.12, 7.82), DBP (-0.82 mmHg; -2.42, 0.79), or BMI (-0.22 kg/m2; -1.83, 1.38). Incidence rate ratios for hospitalizations and emergency department visits were 0.54 (0.14, 1.95) and 0.53 (0.06, 4.72), respectively. CONCLUSIONS: A 6-month produce prescription program for patients with diabetes, implemented during the onset of the COVID-19 pandemic, was not associated with improved glycemic control.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Hager K, Shi P, Li Z, et al. Evaluation of a Produce Prescription Program for Patients With Diabetes: A Longitudinal Analysis of Glycemic Control. Diabetes Care. 2023. PMID: 36812470. doi:10.2337/dc22-1645

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。